Furthermore, the combination of HSP70 inhibitors, such as JG-023, with pharmacological inducers of ER stress (e.g., proteasome and NAE inhibitors) is highly effective in killing CTCL cells. This evidence concerns the gene HSPA1A and primary cutaneous T-cell non-Hodgkin lymphoma.